General Information
Version
9
Revision date
2023-09-27
Product name
Triethylsilane
CAS No.
617-86-7
Emergency telephone
001-800-227-6701, +32 14 57 52 11, 001-201-796-7100, +32 14 57 52 99, 001-800-424-9300, 001-703-527-3887
Icons in SDS
Company Information
company name
Fisher Scientific UK
e-mail address of the competent person responsible for the Safety Data Sheet
begel.sdsdesk@thermofisher.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H225, H400, H410
Hazard statements
Code
Statements
H225
Highly Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
Classification of the substance or mixture
Physical hazards
Flammable liquids Category 2 (H225)
Health hazards
Based on available data, the classification criteria are not met
Environmental hazards
Acute aquatic toxicity Category 1 (H400) Chronic aquatic toxicity Category 1 (H410) Full text of Hazard Statements: see section 16
Signal word
Danger
Hazard statements
H225 - Highly flammable liquid and vapor H410 - Very toxic to aquatic life with long lasting effects
Precautionary statements
P210 - Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower P403 + P233 - Store in a well-ventilated place. Keep container tightly closed
2.3 Other hazards
Decomposes in contact with water Substance is not considered persistent, bioaccumulative and toxic (PBT) / very persistent and very bioaccumulative (vPvB) This product does not contain any known or suspected endocrine disruptors
2.1 Classification of the substance or mixture
CLP Classification - According to GB-CLP Regulations UK SI 2019/720 and UK SI 2020/1567 Physical hazards Flammable liquids Category 2 (H225) Health hazards Based on available data, the classification criteria are not met Environmental hazards Acute aquatic toxicity Category 1 (H400) Chronic aquatic toxicity Category 1 (H410) Full text of Hazard Statements: see section 16